| Name | Title | Contact Details |
|---|---|---|
G�raldine Picaud |
Chief Financial Officer | Profile |
Tim Gooch |
North America Technical Director ISO13485, MDSAP, Supply Chain, Medical Devices | Profile |
Michael Dell |
Assistant General Counsel, Labor and Employment NAM | Profile |
Fulvio Martinez |
Director of Marketing and Communications North America | Profile |
Journey Williams |
SVP of Business Development and R&D | Profile |
ActaCell is a Austin, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics. With its Immune Repertoire Capture™ (IRC™) technology, Atreca has an unparalleled insight into how cancer patients` immune responses can drive better clinical outcomes. Atreca was founded by scientists, industry experts, and investors who share the vision that unlocking the immune response of today`s patients is the key to creating a new generation of therapies. Atreca is looking for talented, entrepreneurial people who are dedicated to making a positive impact on human health.
Translate Bio is a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. Our proprietary mRNA therapeutic platform (MRTTM) is designed to develop product candidates that deliver mRNA carrying instructions to produce intracellular, transmembrane and secreted proteins for therapeutic benefit. We believe that our MRTTM platform is applicable to a broad range of diseases caused by insufficient protein production or where production of proteins can modify disease, including diseases that affect the lung, liver, eye, central nervous system, lymphatic system and circulatory system. Our two lead programs are being developed as treatments for cystic fibrosis (CF) and ornithine transcarbamylase (OTC) deficiency.
Geneos is developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells.
BTI Products is a Bayfield, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.